Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DeepWise is a Chinese healthcare AI company focused on medical imaging, radiology workflow, and hospital data platforms. The company develops commercial AI-assisted diagnostic and imaging software for hospitals and health screening providers, with products spanning chest CT analysis, radiomics research, cloud imaging, image reconstruction, and multimodal medical data management. Its flagship Dr. Wise product family supports radiologists and clinicians with automated detection, triage, and structured analysis for multiple imaging use cases, while MetAI and TrioData X extend into workflow digitization and medical data infrastructure. DeepWise appears to operate as a commercial medtech/software company rather than a therapeutics developer, so it does not have a traditional drug pipeline. The company is venture-backed, privately held, and headquartered in Beijing with additional offices in Shanghai and Hangzhou.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DeepWise.